Things are getting nasty in the 7th Circuit’s big M&A shareholder class action case [Reuters]
FRESENIUS SE S/ADR (FSNUY)
NASDAQ:AMEX Investor Relations:
fresenius.com/index
Company Research
Source: Reuters
Things are getting nasty in the 7th Circuit’s big M&A shareholder class action case - Reuters 9 Min Read (Reuters) - For securities litigators and deal lawyers, the consequences of two related appeals at the 7th U.S. Circuit Court of Appeals, both stemming from shareholder litigation over Akorn’s since-aborted merger with Fresenius Kabi AG, could be huge. The appeals court could provide weapons for federal judges and objecting shareholders who are skeptical about the shareholder class actions filed in the wake of M&A announcements. Or the 7th Circuit could allow plaintiffs’ lawyers in M&A shareholder suits to continue to capitalize on a strategy that allows them to obtain fees without being subject to judges’ authority. It’s no exaggeration to say that the topography of M&A shareholder litigation may change dramatically after the 7th Circuit rules in the Akorn cases. But the latest briefs in the case suggest that for the parties, this is also personal. You need some context to underst
Show less
Read more
Impact Snapshot
Event Time:
FSNUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FSNUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FSNUY alerts
High impacting FRESENIUS SE S/ADR news events
Weekly update
A roundup of the hottest topics
FSNUY
News
- Fresenius Sells Controlling Stake in Vamed Rehab Business to PAI [BNN Bloomberg (Canada)]BNN Bloomberg
- Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company [Yahoo! Finance]Yahoo! Finance
- Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.Business Wire
- Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP [Yahoo! Finance]Yahoo! Finance
- Fresenius Targets Faster Earnings Growth After More Cost Cuts [BNN Bloomberg (Canada)]BNN Bloomberg